Gender differences in global cardiovascular risk factors of obstructive sleep apnea patients
- PMID: 17203415
Gender differences in global cardiovascular risk factors of obstructive sleep apnea patients
Abstract
The morbidity and mortality of obstructive sleep apnea (OSA) are related principally to its cardiovascular complications. Metabolic syndrome (MBS) is recognized as raising the risk of cardiovascular disease. In this study, we analysied the diagnostic value of MBS to predict the diagnosis of severe OSA. Eight-seven subjects (54 males and 33 females) without any cardiac or pulmonary disease referred for evaluation of OSA, had overnight polysomnography. MBS were diagnosed according to NCEP criteria. According to apnea-hypopnea index (AHI), subjects were divided into two groups: severe OSA (AHI>or=30, 26 males, 15 females) and non-severe OSA (AHI<30, 28 males, 18 females). Ages were similar in both OSA groups for both genders. In the severe OSA group, number of patients with MBS was especially higher (in females n=13, 86.6%; in males n=19, 73%) than non-severe OSA (in females 6, 33%, in males 9, 32%). The mean values of the five diagnostic criteria of MBS were significantly higher in severe OSA than non-severe groups in both genders. Analysis of diagnostic value (criteria>or=3) of MBS for predicting the diagnosis of severe OSA in males and females revealed the sensitivity 73% and 86.6%, the specificity 67.8% and 94.4%, positive predictive value 67.9% and 86.7%, negative predictive value 73% and 85.7% respectively. Especially in female patients referred to the sleep clinics, evaluation of MBS criteria may play an important role in predicting severe OSA with high sensitivity and negative predictivity. Furthermore, the presence of MBS in OSA patients might increase cardiovascular complications.
Similar articles
-
Craniofacial abnormalities in Chinese patients with obstructive and positional sleep apnea.Sleep Med. 2008 May;9(4):403-10. doi: 10.1016/j.sleep.2007.04.024. Epub 2007 Jul 19. Sleep Med. 2008. PMID: 17658296
-
Metabolic syndrome in obstructive sleep apnea and related cardiovascular risk.J Cardiovasc Med (Hagerstown). 2006 Nov;7(11):826-9. doi: 10.2459/01.JCM.0000250873.01649.41. J Cardiovasc Med (Hagerstown). 2006. PMID: 17060809 Clinical Trial.
-
Adenotonsillectomy for obstructive sleep apnea in children: outcome evaluated by pre- and postoperative polysomnography.Laryngoscope. 2007 Oct;117(10):1844-54. doi: 10.1097/MLG.0b013e318123ee56. Laryngoscope. 2007. PMID: 17721406
-
Screening for obstructive sleep apnea: an evidence-based analysis.Am J Otolaryngol. 2006 Mar-Apr;27(2):112-8. doi: 10.1016/j.amjoto.2005.09.002. Am J Otolaryngol. 2006. PMID: 16500475 Review.
-
Addressing obstructive sleep apnea in the emergency department.J Emerg Med. 2011 Dec;41(6):728-40. doi: 10.1016/j.jemermed.2010.01.018. Epub 2010 Mar 12. J Emerg Med. 2011. PMID: 20227230 Review.
Cited by
-
Do sleep disorders and associated treatments impact glucose metabolism?Drugs. 2009;69 Suppl 2:13-27. doi: 10.2165/11531150-000000000-00000. Drugs. 2009. PMID: 20047348 Review.
-
Is the clinical presentation different between men and women admitting to the sleep laboratory?Sleep Breath. 2009 Aug;13(3):295-8. doi: 10.1007/s11325-008-0243-1. Epub 2009 Jan 24. Sleep Breath. 2009. PMID: 19169724
Publication types
MeSH terms
LinkOut - more resources
Medical